Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Dermatological manifestations associated with COVID-19 and COVID-19 vaccination: results from the Lebanese COVID registry.
Int J Dermatol. 2023 Oct;62(10):1248-1256. doi: 10.1111/ijd.16815. Epub 2023 Aug 28.
Int J Dermatol. 2023.
PMID: 37638543
Varicella-Zoster Virus Gastritis: Case Report and Review of the Literature.
Nohr EW, Itani DM, Andrews CN, Kelly MM.
Nohr EW, et al.
Int J Surg Pathol. 2017 Aug;25(5):449-452. doi: 10.1177/1066896917696751. Epub 2017 Mar 1.
Int J Surg Pathol. 2017.
PMID: 28381144
Review.
We report varicella-zoster virus (VZV) gastritis in a 70-year-old woman postchemotherapy for lymphoma, presenting with abdominal pain, vomiting, and delirium without rash. A gastric biopsy demonstrated viral inclusions but posed a diagnostic challenge as immunohistochemist …
We report varicella-zoster virus (VZV) gastritis in a 70-year-old woman postchemotherapy for lymphoma, presenting with abdominal pain, vomit …
Item in Clipboard
Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors.
Nishimura T, Fujimoto H, Fujiwara T, Ito K, Fujiwara A, Yuda H, Itani H, Naito M, Kodama S, Furuhashi K, Yagi A, Saiki H, Yasuma T, Okano T, Tomaru A, Tanigawa M, Yoshida M, Hataji O, Ibata H, D'Alessandro-Gabazza CN, Gabazza EC, Kobayashi T.
Nishimura T, et al.
Cancer Med. 2024 Apr;13(8):e7188. doi: 10.1002/cam4.7188.
Cancer Med. 2024.
PMID: 38629295
Free PMC article.
Seventeen patients had grade 1-2 immune-related adverse events, and nine (including overlapping cases) had grade 3. The most frequent immune-related adverse event was a skin rash. The median survival time was 22 months in patients with immune-related adverse events and 9.3 …
Seventeen patients had grade 1-2 immune-related adverse events, and nine (including overlapping cases) had grade 3. The most frequent immune …
Item in Clipboard
Cite
Cite